CTOs on the Move

Symbiomix Therapeutics

www.symbiomix.com

 
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.symbiomix.com
  • 105 Lock Street Suite 409
    Newark, NJ USA 07103-3576
  • Phone: 609.722.7250

Executives

Name Title Contact Details

Funding

Symbiomix Therapeutics raised $41M on 05/06/2015

Similar Companies

American Transplant Foundation

American Transplant Foundation is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CycleCast

CycleCast makes studio-quality indoor cycling more accessible than ever by delivering hit music and motivational instructors straight to your iPhone. CycleCast works with any indoor bike and brings the energy, intensity, and community of indoor cycling...

Body Logic

Body Logic is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

One GI

One GI is a physician-centric gastroenterology management services organization (MSO) that partners with gastroenterologists to help them manage, optimize, and grow their independent gastroenterology practices.

Social Interest Solutions

Social Interest Solutions is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oakland, CA. To find more information about Social Interest Solutions, please visit www.oneeapp.org